# Theranova Versus High-flux Dialyzer on Preservation of Residual Renal Function

> **NCT04211571** · NA · COMPLETED · sponsor: **Kyungpook National University Hospital** · enrollment: 80 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DEVICE:** Theranova 400 dialyzer
- **DEVICE:** High-flux dialyzer

## Key facts

- **NCT ID:** NCT04211571
- **Lead sponsor:** Kyungpook National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-23
- **Primary completion:** 2023-09-17
- **Final completion:** 2023-09-24
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-11-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04211571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04211571, "Theranova Versus High-flux Dialyzer on Preservation of Residual Renal Function". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04211571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*